DE602006014574D1 - Sequenz von nukleotiden und peptiden gse 24.2 aus dyskerin zur herbeiführung von telomerase-aktivität, herstellungsverfahren dafür sowie therapeutische zusammensetzungen und anwendungen davon - Google Patents

Sequenz von nukleotiden und peptiden gse 24.2 aus dyskerin zur herbeiführung von telomerase-aktivität, herstellungsverfahren dafür sowie therapeutische zusammensetzungen und anwendungen davon

Info

Publication number
DE602006014574D1
DE602006014574D1 DE602006014574T DE602006014574T DE602006014574D1 DE 602006014574 D1 DE602006014574 D1 DE 602006014574D1 DE 602006014574 T DE602006014574 T DE 602006014574T DE 602006014574 T DE602006014574 T DE 602006014574T DE 602006014574 D1 DE602006014574 D1 DE 602006014574D1
Authority
DE
Germany
Prior art keywords
sequence
dyskerin
gse
telomerase activity
manufact
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602006014574T
Other languages
German (de)
English (en)
Inventor
Abellon Rosario Perona
Pinilla Rosario Machado
Garzon Leandro Sastre
Perez Isabel Sanchez
Ibanez Jose Ramon Murguia
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Consejo Superior de Investigaciones Cientificas CSIC
Universidad Politecnica de Valencia
Universidad Autonoma de Madrid
Original Assignee
Consejo Superior de Investigaciones Cientificas CSIC
Universidad Politecnica de Valencia
Universidad Autonoma de Madrid
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Consejo Superior de Investigaciones Cientificas CSIC, Universidad Politecnica de Valencia, Universidad Autonoma de Madrid filed Critical Consejo Superior de Investigaciones Cientificas CSIC
Publication of DE602006014574D1 publication Critical patent/DE602006014574D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Vascular Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Dermatology (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Psychology (AREA)
  • Hematology (AREA)
DE602006014574T 2005-10-14 2006-10-11 Sequenz von nukleotiden und peptiden gse 24.2 aus dyskerin zur herbeiführung von telomerase-aktivität, herstellungsverfahren dafür sowie therapeutische zusammensetzungen und anwendungen davon Active DE602006014574D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200502511A ES2325431B1 (es) 2005-10-14 2005-10-14 Secuencia de nucleotidos y peptidos gse 24.2 de la disquerina inductores de la actividad telomerasa, procedimiento de obtencion, composiciones terapeuticas y sus aplicaciones.
PCT/ES2006/070152 WO2007090911A1 (es) 2005-10-14 2006-10-11 Secuencia de nucleótidos y péptidos gse 24.2 de la disquerina inductores de la actividad telomerasa, procedimiento de obtención, composiciones terapéuticas y sus aplicaciones

Publications (1)

Publication Number Publication Date
DE602006014574D1 true DE602006014574D1 (de) 2010-07-08

Family

ID=38344881

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006014574T Active DE602006014574D1 (de) 2005-10-14 2006-10-11 Sequenz von nukleotiden und peptiden gse 24.2 aus dyskerin zur herbeiführung von telomerase-aktivität, herstellungsverfahren dafür sowie therapeutische zusammensetzungen und anwendungen davon

Country Status (10)

Country Link
US (2) US9074194B2 (https=)
EP (1) EP1947175B1 (https=)
JP (1) JP5560398B2 (https=)
AT (1) ATE469212T1 (https=)
CA (1) CA2625981A1 (https=)
DE (1) DE602006014574D1 (https=)
DK (1) DK1947175T3 (https=)
ES (2) ES2325431B1 (https=)
PT (1) PT1947175E (https=)
WO (1) WO2007090911A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2334736B1 (es) * 2007-11-23 2011-02-02 Consejo Superior De Investigaciones Cientificas (Titular Al 90%) Uso de agentes inductores gse24.2 para la elaboracion de composiciones farmaceuticas para el tratamiento de enfermedades que cursan con senescencia celular.
WO2014122346A1 (es) * 2013-02-05 2014-08-14 Consejo Superior De Investigaciones Cientificas (Csic) Bionanopartículas biodegradables para liberación del péptido gse24-2, procedimiento de obtención y utilización
PT3061815T (pt) 2013-10-25 2020-05-18 Univ Madrid Autonoma Péptidos derivados de gse 24.2 para o tratamento de doenças causadas pelo stresse oxidativo e danos no adn
US20220313782A1 (en) * 2019-05-02 2022-10-06 Board Of Regents, The University Of Texas System Methods and compositions involving tert activating therapies
KR20250162845A (ko) 2023-03-17 2025-11-19 콘세호 수페리오르 데 인베스티가시오네스 시엔티피카스 (Csic) Gse24.2 유래 펩타이드 및 이의 용도
ES2989543A1 (es) * 2023-05-22 2024-11-26 Alodia Farm S L U Peptidos para su uso en la prevencion y/o tratamiento de radiodermitis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5350836A (en) * 1989-10-12 1994-09-27 Ohio University Growth hormone antagonists
DE19817118C1 (de) * 1998-04-17 1999-10-28 Deutsches Krebsforsch Dyskerin und dafür codierende DNA-Moleküle, diese enthaltende Vektoren, Antikörper gegen Dyskerin und die Verwendung dieser Gegenstände

Also Published As

Publication number Publication date
WO2007090911A1 (es) 2007-08-16
JP5560398B2 (ja) 2014-07-23
US9074194B2 (en) 2015-07-07
US20090202503A1 (en) 2009-08-13
JP2009511036A (ja) 2009-03-19
US9587002B2 (en) 2017-03-07
ES2325431B1 (es) 2010-06-28
PT1947175E (pt) 2010-09-02
CA2625981A1 (en) 2007-08-16
EP1947175A1 (en) 2008-07-23
ATE469212T1 (de) 2010-06-15
US20150337022A1 (en) 2015-11-26
EP1947175B1 (en) 2010-05-26
ES2360238T3 (es) 2011-06-02
ES2325431A1 (es) 2009-09-03
DK1947175T3 (da) 2010-09-27

Similar Documents

Publication Publication Date Title
IL213319A (en) Polylysis peptides for use in the treatment of bacterial infections
CY1116285T1 (el) Ανασυνδυασμενες ν-γλυκοζυλιωμενες πρωτεϊνες απο προκαρυωτικα κυτταρα
ATE542901T1 (de) Glykosyliertes il-7, herstellung und anwendungen
EP1548032A4 (en) KDR-PEPTIDES AND VACCINES CONTAINING THEM
WO2008118017A3 (en) Prame derived peptides and immunogenic compositions comprising these
ATE417595T1 (de) Keratin-bindende polypeptide
EA201100070A1 (ru) Туберкулезный белок rv2386c, композиции и их применения
GB2348808A (en) Methods and compositions for desensitisation
HRP20171694T1 (hr) Novi pripravci i postupci
WO2007076162A3 (en) Antimicrobial cathelicidin peptides
ATE506957T1 (de) Prophylaktisches/therapeutisches mittel für neurodegenerative erkrankungen
DE602005020165D1 (de) Verfahren zur herstellung von l-arginin, l-ornithin oder l-citrullin
UA100127C2 (ru) Пептид cdh3 и лекарственное средство, содержащее его
JP2006506942A5 (https=)
IL206157A (en) Pancreatic elastase protein of type 1, a nucleic acid molecule encoded by a protein
WO2008040190A8 (fr) Petits peptides pour anti-angiogenèse et utilisation de ceux-ci
DE602006014574D1 (de) Sequenz von nukleotiden und peptiden gse 24.2 aus dyskerin zur herbeiführung von telomerase-aktivität, herstellungsverfahren dafür sowie therapeutische zusammensetzungen und anwendungen davon
NZ596043A (en) Allergy inhibitor compositions and kits and methods of using the same
WO2010103515A3 (en) Compositions and methods for prevention and treatment of neurodegenerative diseases
ATE551353T1 (de) Protein mit fusogener wirkung, nukleinsäuresequenzen, die für dieses protein codieren und pharmazeutische zusammensetzungen, die dieses enthalten
WO2007010080A3 (es) Nuevos dendrímeros carbosilanos, su preparación y sus usos
WO2010011994A3 (en) Polypeptides and uses thereof
WO2006116763A3 (en) Lawsonia intracellularis immunological proteins
MX2011004176A (es) Peptido-epitope rab6kifl/kif20a y vacunas que contienen el mismo.
WO2003092736A3 (en) Peptide nucleic acid conjugates with transporter peptides

Legal Events

Date Code Title Description
8364 No opposition during term of opposition